Italfarmaco
Clinical trials sponsored by Italfarmaco, explained in plain language.
-
New hope for High-Risk blood cancer patients: givinostat faces off against standard therapy
Disease control Recruiting nowThis phase 3 trial compares the experimental drug givinostat to the standard drug hydroxyurea in 220 adults with high-risk polycythemia vera, a blood cancer that increases red blood cells and raises clot risk. The study measures how well each drug controls blood counts and spleen…
Phase: PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Hope for duchenne: Long-Term drug safety trial now recruiting
Disease control Recruiting nowThis study looks at the long-term safety and effects of the drug givinostat in people with Duchenne muscular dystrophy (DMD). It is open to those who have already taken part in a previous givinostat study. The goal is to track side effects and see how well the drug works over tim…
Phase: PHASE2, PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC